Leavell Investment Management Inc. grew its holdings in shares of BB&T Co. (NYSE:BBT) by 7.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 42,204 shares of the insurance provider’s stock after buying an additional 3,050 shares during the period. Leavell Investment Management Inc.’s holdings in BB&T were worth $2,073,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. BlackRock Inc. boosted its holdings in shares of BB&T by 10.7% during the 1st quarter. BlackRock Inc. now owns 59,338,587 shares of the insurance provider’s stock valued at $2,761,026,000 after buying an additional 5,759,090 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of BB&T by 1.5% during the 1st quarter. Northern Trust Corp now owns 11,293,602 shares of the insurance provider’s stock valued at $525,492,000 after buying an additional 163,933 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of BB&T by 6.8% during the 4th quarter. Geode Capital Management LLC now owns 9,220,118 shares of the insurance provider’s stock valued at $398,655,000 after buying an additional 590,366 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of BB&T by 0.6% during the 1st quarter. American Century Companies Inc. now owns 9,180,892 shares of the insurance provider’s stock valued at $427,187,000 after buying an additional 55,869 shares in the last quarter. Finally, Boston Partners boosted its holdings in shares of BB&T by 59.9% during the 1st quarter. Boston Partners now owns 5,737,854 shares of the insurance provider’s stock valued at $266,982,000 after buying an additional 2,150,335 shares in the last quarter. Hedge funds and other institutional investors own 67.96% of the company’s stock.

In other news, insider David Hudson Weaver sold 21,705 shares of BB&T stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $51.44, for a total value of $1,116,505.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Donta L. Wilson sold 3,418 shares of BB&T stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $49.16, for a total value of $168,028.88. Following the completion of the transaction, the insider now directly owns 14,911 shares of the company’s stock, valued at approximately $733,024.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,623 shares of company stock valued at $1,405,359. 0.49% of the stock is owned by insiders.

BBT opened at $51.20 on Tuesday. The stock has a 50-day moving average of $49.85. The company has a current ratio of 0.88, a quick ratio of 0.87 and a debt-to-equity ratio of 0.79. The stock has a market cap of $39.22 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 1.31 and a beta of 1.14. BB&T Co. has a 1 year low of $40.68 and a 1 year high of $53.08.

BB&T (NYSE:BBT) last posted its quarterly earnings results on Thursday, July 18th. The insurance provider reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.04. The firm had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.01 billion. BB&T had a return on equity of 12.23% and a net margin of 23.58%. BB&T’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.01 EPS. As a group, equities analysts anticipate that BB&T Co. will post 4.23 EPS for the current fiscal year.

A number of analysts have recently commented on the stock. Deutsche Bank set a $129.00 target price on shares of Proofpoint and gave the company a “hold” rating in a report on Friday. Morgan Stanley cut shares of Silicon Motion Technology from an “equal weight” rating to an “underweight” rating in a report on Monday, April 22nd. JPMorgan Chase & Co. assumed coverage on shares of Pinduoduo in a report on Tuesday, July 9th. They set an “underweight” rating and a $20.48 target price on the stock. UBS Group boosted their target price on shares of Willis Towers Watson from $202.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Eight analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $54.04.

BB&T Profile

BB&T Corporation, a holding company, provides banking and trust services for small and mid-size businesses, public agencies, local governments, corporations, and individuals in the Southeastern and Mid-Atlantic United States. The company operates through four segments: Community Banking Retail and Consumer Finance, Community Banking Commercial, Insurance Holdings, and Financial Services and Commercial Finance.

Recommended Story: What is a back-end load?

Want to see what other hedge funds are holding BBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BB&T Co. (NYSE:BBT).

Institutional Ownership by Quarter for BB&T (NYSE:BBT)

Receive News & Ratings for BB&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BB&T and related companies with MarketBeat.com's FREE daily email newsletter.